Ann: Pancreatic cancer clinical study update, page-26

all reasonable points matrix.
i invested a small package at 12c in the hope that this may show promising results in the next 2-3 years.
there is really no point investing in this type of stock short term and then panicking when it drops 20-30%. you have to expect when in between major announcements that there will be fatigue from investors who invested hoping for a quick buck, often based on a site like motley fool giving a superficial plug for it.
if i lose half or more of my small parcel, so be it, but i think the technology makes sense and there hs been good progress in terms of getting multicentre trials at world leading centres up and running.
the ce mark is the next major catalyst so its overdue and that is frustrating but that is also pretty typical in such processes for biotech companies.

im happy holding for a couple of years, but would advise against anyone investing more than 3-5% of your portfolio given the high risk.